Evidence map›Paper›PMID 30940289›Full record

ArticleOncology research2019

Anticancer Effects of

Yue Cai, Chizhi Zhang, Lei Zhan, Liangbin Cheng, Dingbo Lu, Xiaodong Wang, Hanlin Xu, Shuxue Wang, Deng Wu, Lianguo Ruan

Open access · hybridAbstract read
In one paragraph

Article in Oncology research, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
0.8field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it, 19 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Yue CaiClinical Medical College of Hubei University of Chinese Medicine, Wuhan, P.R. China.
Chizhi ZhangClinical Medical College of Hubei University of Chinese Medicine, Wuhan, P.R. China.
Lei ZhanClinical Medical College of Hubei University of Chinese Medicine, Wuhan, P.R. China.
Liangbin ChengClinical Medical College of Hubei University of Chinese Medicine, Wuhan, P.R. China.
Dingbo LuClinical Medical College of Hubei University of Chinese Medicine, Wuhan, P.R. China.
Xiaodong WangClinical Medical College of Hubei University of Chinese Medicine, Wuhan, P.R. China.
Hanlin XuCollege of Pharmacy of Hubei University of Chinese Medicine, Wuhan, P.R. China.
Shuxue WangWuhan Hospital of Traditional Chinese Medicine Department of Pediatrics, Wuhan, P.R. China.
Deng WuClinical Medical College of Hubei University of Chinese Medicine, Wuhan, P.R. China.
Lianguo RuanInfectious Disease of Wuhan Medical Treatment Center, Wuhan, P.R. China.
Hubei University of Chinese Medicine · CNJinyintan Hospital · CNWuhan City Chinese Medicine Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The thorns of

Indexed as

AnimalsApoptosisApoptosis Regulatory ProteinsBreast NeoplasmsCarcinoma, HepatocellularFemaleGene Expression Regulation, NeoplasticGleditsiaHumansLiver NeoplasmsMammary Neoplasms, AnimalMatrix Metalloproteinase 2Matrix Metalloproteinase 9MicroRNAsPlant ExtractsPTEN PhosphohydrolaseApoptosis Regulatory ProteinsMatrix Metalloproteinase 2Matrix Metalloproteinase 9MicroRNAsMIRN181 microRNA, ratMIRN183 microRNA, ratmirn21 microRNA, ratPdcd4 protein, ratPlant ExtractsPTEN PhosphohydrolasePten protein, ratTissue Inhibitor of Metalloproteinase-3

Identifiers

PMID30940289
PMCPMC7848454
OpenAlexW2935314819

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.